rs864321635
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_002968.3(SALL1):c.3160C>T(p.Arg1054*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002968.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Townes-Brocks syndrome 1 Pathogenic:1Other:1
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000219151 /PMID: 23069192). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Townes syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg1054*) in the SALL1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 271 amino acid(s) of the SALL1 protein. This variant is not present in population databases (gnomAD no frequency). This variant has been reported to segregate with multiple congenital anomaly-intellectual disability in a family (PMID: 23069192). In this family, two affected siblings were homozygous for this variant. Eleven heterozygous carriers from this family were clinically evaluated with emphasis on minor Townes-Brocks syndrome (TBS) features, and were all found to be unaffected. Another heterozygous carrier, who was not available for thorough clinical evaluation, was also reported to be healthy. However, this variant has also been observed in different families, where the heterozygous probands and heterozygous family members had clinical features consistent with TBS (Invitae). ClinVar contains an entry for this variant (Variation ID: 219151). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:1
Reported in the homozygous state in two individuals from the same family with multiple congenital anomalies including imperforate anus and triphalangeal thumbs in published literature (Vodopiutz et al., 2013); parents are noted to be heterozygous and unaffected; Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26962299, 23069192) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at